---
figid: PMC3158598__zlj9991015200001
figlink: /pmc/articles/PMC3158598/figure/F1/
number: F1
caption: Representation of PTEN/Akt/mTOR (phosphatase and tensin homolog/Akt/mammalian
  target of rapamycin) pathway. CCI-779, temsirolimus; EIF-4E, eukaryotic translation
  initiation factor 4E; P13K, phosphatidylinositol 3-kinase; P70s6k, phosphorylated
  s6 kinase; Rad 001, everolimus; RTK, receptor tyrosine kinase.
pmcid: PMC3158598
papertitle: 'Phase II Study of Temsirolimus in Women With Recurrent or Metastatic
  Endometrial Cancer: A Trial of the NCIC Clinical Trials Group.'
reftext: Amit M. Oza, et al. J Clin Oncol. 2011 Aug 20;29(24):3278-3285.
pmc_ranked_result_index: '133850'
pathway_score: 0.8451751
filename: zlj9991015200001.jpg
figtitle: Representation of PTEN/Akt/mTOR (phosphatase and tensin homolog/Akt/mammalian
  target of rapamycin) pathway
year: '2011'
organisms: Homo sapiens
ndex: f081000e-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3158598__zlj9991015200001.html
  '@type': Dataset
  description: Representation of PTEN/Akt/mTOR (phosphatase and tensin homolog/Akt/mammalian
    target of rapamycin) pathway. CCI-779, temsirolimus; EIF-4E, eukaryotic translation
    initiation factor 4E; P13K, phosphatidylinositol 3-kinase; P70s6k, phosphorylated
    s6 kinase; Rad 001, everolimus; RTK, receptor tyrosine kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EIF4EBP1
  - HRAS
  - NRAS
  - MTOR
  - AKT2
  - DLX4
  - SERPINA4
  - PTEN
  - AKT3
  - AKT1
  - RPS6KB1
  - RPS6KB2
  - KRAS
  - EIF4E
  - Temsirolimus
  - Ridaforolimus
  - Rapamycin
  - Cancer
genes:
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: -BP1
  symbol: BP1
  source: hgnc_alias_symbol
  hgnc_symbol: DLX4
  entrez: '1748'
- word: PI4,5P,
  symbol: PI4
  source: hgnc_prev_symbol
  hgnc_symbol: SERPINA4
  entrez: '5267'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P70s6k
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: P70s6k
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: EIF-4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Ridaforolimus
  source: MESH
  identifier: C515074
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3158598__F1
redirect_from: /figures/PMC3158598__F1
figtype: Figure
---
